Visits: 11
Biogen’s Alzheimer’s drug, Adhulem, generated $2 million in revenue in the first few weeks of its approval, the company said in its second-quarter earnings. Read More Go To Source
Visits: 11
Biogen’s Alzheimer’s drug, Adhulem, generated $2 million in revenue in the first few weeks of its approval, the company said in its second-quarter earnings. Read More Go To Source
Copyright © 2020 | Fastinews.com